Xian‐Cheng Jiang
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 33
- Biochemistry top 0.2%
- Lipid metabolism and biosynthesis 25
- Surgery top 0.5%
- Cholesterol and Lipid Metabolism 48
- Cancer Research top 1%
- Molecular Biology top 1%
- Sphingolipid Metabolism and Signaling 63
- Peroxisome Proliferator-Activated Receptors 28
- Lipid Membrane Structure and Behavior 26
-
- Caveolin-1 and cellular processes 25
-
- Erythrocyte Function and Pathophysiology 22
Xian‐Cheng Jiang
177 papers receiving 9.6k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Endocrinology, Diabetes and Metabolism 2.2k
- Biochemistry 942
- Surgery 3.9k
- Cancer Research 1.2k
- Molecular Biology 5.2k
Countries citing papers authored by Xian‐Cheng Jiang
This map shows the geographic impact of Xian‐Cheng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian‐Cheng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian‐Cheng Jiang more than expected).
Fields of papers citing papers by Xian‐Cheng Jiang
This network shows the impact of papers produced by Xian‐Cheng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian‐Cheng Jiang. The network helps show where Xian‐Cheng Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xian‐Cheng Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 14 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 10 | |
| 6 | 2021 | 17 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 10 | |
| 11 | 2015 | 33 | |
| 12 | 2013 | 118 | |
| 13 | 2013 | 46 | |
| 14 | 2008 | 55 | |
| 15 | 2008 | 56 | |
| 16 | 2004 | 34 | |
| 17 | 1996 | 40 | |
| 18 | 1995 | 27 | |
| 19 | 1994 | 198 | |
| 20 | 1993 | 112 |
About Xian‐Cheng Jiang
Xian‐Cheng Jiang is a scholar working on Biochemistry, Cell Biology and Endocrinology, Diabetes and Metabolism, having authored 179 papers that have together received 9.8k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (63 papers), Cholesterol and Lipid Metabolism (48 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (33 papers), Peroxisome Proliferator-Activated Receptors (28 papers), Lipid Membrane Structure and Behavior (26 papers), Caveolin-1 and cellular processes (25 papers), Lipid metabolism and biosynthesis (25 papers) and Erythrocyte Function and Pathophysiology (22 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.2k citations), Biochemistry (942 citations) and Surgery (3.9k citations). Xian‐Cheng Jiang has collaborated with scholars based in United States, China and France. Frequent co-authors include Alan R. Tall, Zhiqiang Li, Mohammad Reza Hojjati, Can Bruce, Guoqing Cao, Ming‐Shang Kuo, A Walsh, Luis B. Agellon, Chongmin Huan and Hongwen Zhou. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.